Serenace was tested in its two formulations of dextrose and saline base and the results confirm no significant differences between the two preparations, either in their efficacy and acceptability or in the control of presenting symptoms.
Get full access to this article
View all access options for this article.
References
1.
CraneG E (1967) A review of the clinical literature on haloperidol. International Journal of Neuropsychiatry3, 110, Supplement 1.
2.
FeldmanP E (1969) Parenteral haloperidol in controlling patient behaviour during acute psychotic episodes. Current Therapeutic Research11, 6, 362.
3.
LapollaANashL R (1966) A butyrophenone (haloperidol) for the treatment of institutionalized patients. International Journal of Neuropsychiatry21 (2), 129.
4.
ManP LChenC H (1973) Rapid tranquillization of acutely psychotic patients with intramuscular haloperidol and chlorpromazine. Psychosomatics14, 59.
5.
OldhamA JBottM (1971) The management of excitement in a general hospital psychiatric ward by high dosage haloperidol. Acta Psychiatrica Scandinavica47, 369.
6.
SangiovanniF (1973) Rapid control of psychotic excitement states with intramuscular haloperidol. American Journal of Psychiatry130, 10, 1155.
7.
SiegelS (1956) Non-Parametric Statistics for The Behavioural Sciences. Chapter 6, p 116, McGraw-Hill, USA.
8.
SlotnickV B (1971) Management of the acutely agitated psychiatric patient with parenteral neuroleptics: A comparative symptom effectiveness profile of haloperidol and chlorpromazine. Fifth World Congress of Psychiatry, Mexico City.
